Лучшие больницы для «Adenoidectomy Surgery» в Хайдарабад, Индия

The adenoids are a single mass of lymphoid tissue located on the posterior wall of the nasopharynx. In childhood, they are immunologically active and reach peak size between ages 3 and 7, after which they typically involute. When they remain pathologically enlarged — due to recurrent viral or bacterial infections, allergic inflammation, or anatomical predisposition — they physically obstruct the posterior choanae, block Eustachian tube drainage, and generate a reservoir for chronic bacterial colonisation. The resulting clinical syndrome includes obligate mouth breathing, hyponasal speech, chronic serous otitis media with associated conductive hearing loss, recurrent acute otitis media, chronic sinusitis, and obstructive sleep apnoea (OSA). In children, untreated adenoid hypertrophy is associated with adenoid facies (elongated facial morphology, high arched palate, open bite) and, importantly, neurocognitive consequences from nocturnal hypoxaemia, including impaired attention, learning difficulties, and behavioural disturbances.

• **Primary indications for adenoidectomy:**
• Adenoid hypertrophy causing significant nasal obstruction with mouth breathing despite ≥6 weeks of intranasal corticosteroid therapy
• Recurrent acute otitis media: ≥3 episodes in 6 months or ≥4 episodes in 12 months, especially with concurrent adenoid hypertrophy confirmed on flexible nasopharyngoscopy or lateral neck X-ray
• Chronic serous otitis media (glue ear) with bilateral conductive hearing loss >20 dB and adenoid hypertrophy contributing to Eustachian tube dysfunction; typically combined with bilateral myringotomy and grommet insertion
• Obstructive sleep apnoea diagnosed by overnight polysomnography (PSG) showing an Apnoea-Hypopnoea Index (AHI) >1 event/hour in children, with adenoid hypertrophy identified as a primary anatomical contributor
• +22 more

**1. Traditional Curettage Adenoidectomy (Blind Technique)** The oldest technique uses a St. Clair Thompson or Beckmann adenoid curette introduced transorally and passed blindly into the nasopharynx to scrape adenoid tissue off the posterior nasopharyngeal wall. Haemostasis is achieved by postnasal packing. While still practised in low-resource settings due to speed and low equipment cost, the blind technique has known limitations: incomplete resection (particularly of lateral choanal adenoid tissue near the Eustachian tube cushions), risk of inadvertent injury to the Eustachian tube orifices, and a higher recurrence rate of 10–20% compared to visualised techniques. It is no longer considered the standard of care in high-volume ENT centres.

**2. Endoscopic-Assisted Adenoidectomy with Microdebrider (Power-Assisted Technique — Current Gold Standard)** A 0° or 70° rigid nasal endoscope is introduced transnasally to provide continuous direct visualisation of the nasopharynx. A microdebrider — a powered rotating shaver with simultaneous suction-irrigation — is introduced transorally to remove adenoid tissue under endoscopic guidance. This technique allows the surgeon to identify and preserve the Eustachian tube orifices, remove lateral adenoid tissue that curves into the choanae (a common site of residual obstruction), and achieve a consistently complete resection. Blood loss is typically <20 mL. The visualised approach reduces recurrence rates to <5% and is the preferred technique at accredited centres in both India and the UAE. In the context of concurrent grommet insertion, both procedures are completed in a single anaesthetic episode lasting 20–40 minutes total.

**3. Coblation Adenoidectomy (Plasma-Mediated Ablation)** Coblation (controlled ablation) uses bipolar radiofrequency energy delivered in a saline medium to create a precisely controlled plasma field at the tissue surface. This dissolves molecular bonds in adenoid tissue at a temperature of 40–70°C — dramatically lower than electrocautery (>400°C) or laser — minimising collateral thermal injury to surrounding mucosa, the skull base (where adenoid tissue may abut the pharyngobasilar fascia overlying the prevertebral muscles), and the Eustachian tube orifices. Coblation adenoidectomy is performed under direct endoscopic vision and is associated with less post-operative pain, lower risk of post-operative haemorrhage, and faster mucosal healing compared to electrocautery-assisted techniques. It is the technique of choice for patients with coagulopathy (after optimisation), revision adenoidectomy (where tissue planes are scarred), and in centres with OSA-dominant referral patterns where complete lateral wall clearance is critical.

**4. KTP Laser Adenoidectomy** The potassium-titanyl-phosphate (KTP) laser (532 nm wavelength) can be used under endoscopic visualisation to vaporise adenoid tissue with haemostatic precision. While effective, laser equipment costs limit its widespread adoption, and Coblation has largely replaced laser as the preferred energy-based technique due to superior safety profile at lower tissue temperatures. KTP laser remains available at select tertiary ENT centres in Mumbai, Delhi, and Dubai.

**Phase 1 — Pre-Operative Assessment (Day -7 to Day -1)**

• GAF Healthcare's clinical coordinator receives medical records, imaging, and GP/ENT referral letters and routes them to the appointed ENT surgical team within 24–48 hours.
• Remote pre-operative teleconsultation with the operating ENT surgeon to review nasopharyngoscopy findings, PSG data, audiometry, and coagulation results.
• For international patients, GAF Healthcare facilitates pre-operative blood work and any outstanding investigations (e.g., CT nasopharynx if not yet performed) at a partner diagnostic centre within 24 hours of arrival.
• Pre-operative anaesthesia assessment — paediatric patients undergo a structured airway assessment given the frequent co-existence of OSA, which necessitates heightened post-operative monitoring protocols.
• Nil by mouth (NBM) instructions: 6 hours for solids, 4 hours for breast milk (infants), 2 hours for clear fluids.
• Consent process: The surgeon explains the chosen technique (microdebrider vs. Coblation), the scope of concurrent procedures (grommets if indicated), and potential complications.

**Phase 2 — Day of Surgery (Day 0)**